闯入
发表于 2025-3-28 16:35:04
https://doi.org/10.1007/978-3-662-24745-7l hypertension, many obstacles may occur which impair his/her ability to stay on therapy. In this chapter, we will review the determinants and barriers to adherence in hypertension utilizing the WHO Multidimensional Adherence Model classification, showing in which phase of the adherence process they
凹处
发表于 2025-3-28 20:35:14
https://doi.org/10.1007/978-3-662-24745-7 poor with less than 50% of people adhering to treatment as prescribed. Many people do not even begin taking the medication, and even when treatment is initiated, early discontinuation is common. There have been many adherence interventions developed to promote adherence; however, the effectiveness
我悲伤
发表于 2025-3-29 01:04:02
http://reply.papertrans.cn/29/2831/283029/283029_43.png
概观
发表于 2025-3-29 04:26:23
http://reply.papertrans.cn/29/2831/283029/283029_44.png
ARC
发表于 2025-3-29 08:53:09
https://doi.org/10.1007/978-3-662-24745-7o discontinuation of therapy and may also consider the intensity of medication-taking behaviour within this interval. Registers on pharmacy claims data have been proposed as the golden standard in medication persistence research. Generally, persistence rate decreases with time. Medication persistenc
judiciousness
发表于 2025-3-29 12:29:10
http://reply.papertrans.cn/29/2831/283029/283029_46.png
生意行为
发表于 2025-3-29 16:08:20
http://reply.papertrans.cn/29/2831/283029/283029_47.png
评论者
发表于 2025-3-29 20:43:43
http://reply.papertrans.cn/29/2831/283029/283029_48.png
Highbrow
发表于 2025-3-30 00:32:27
Drug Adherence in Hypertension and Cardiovascular Protection978-3-319-76593-8Series ISSN 2366-4606 Series E-ISSN 2366-4614
Fillet,Filet
发表于 2025-3-30 07:12:09
http://reply.papertrans.cn/29/2831/283029/283029_50.png